IARC致癌物名单(英文根据证据强度分类排名)

1AgentsClassifiedbytheIARCMonographs,Volumes1–112CASNoAgentGroupVolumeYear000075-07-0Acetaldehydeassociatedwithconsumptionofalcoholicbeverages1100E2012Achesonprocess,occupationalexposureassociatedwith1111InprepAcidmists,stronginorganic154,100F2012001402-68-2Aflatoxins156,82,100F2012Alcoholicbeverages144,96,100E2012Aluminiumproduction134,Sup7,100F2012000092-67-14-Aminobiphenyl11,Sup7,99,100F2012Arecanut185,100E2012000313-67-7Aristolochicacid(NB:OverallevaluationupgradedtoGroup1basedonmechanisticandotherrelevantdata)182,100A2012000313-67-7Aristolochicacid,plantscontaining182,100A2012007440-38-2Arsenicandinorganicarseniccompounds123,Sup7,100C2012001332-21-4013768-00-8012172-73-5017068-78-9012001-29-5012001-28-4014567-73-8Asbestos(allforms,includingactinolite,amosite,anthophyllite,chrysotile,crocidolite,tremolite)(NB:Mineralsubstances(e.g.talcorvermiculite)thatcontainasbestosshouldalsoberegardedascarcinogenictohumans.)114,Sup7,100C2012Auramineproduction1Sup7,99,100F2012000446-86-6Azathioprine126,Sup7,100A2012000071-43-2Benzene129,Sup7.100F2012000092-87-5Benzidine129,Sup7,99,100F2012Benzidine,dyesmetabolizedto(NB:OverallevaluationupgradedtoGroup1basedonmechanisticandotherrelevantdata)199,100F2012000050-32-8Benzo[a]pyrene(NB:OverallevaluationupgradedtoGroup1basedonmechanisticandotherrelevantdata)192,100F2012007440-41-7Berylliumandberylliumcompounds158,100C2012Betelquidwithtobacco185,100E2012Betelquidwithouttobacco185,100E20122AgentsClassifiedbytheIARCMonographs,Volumes1–112CASNoAgentGroupVolumeYear000542-88-1000107-30-2Bis(chloromethyl)ether;chloromethylmethylether(technical-grade)14,Sup7,100F2012000055-98-1Busulfan14,Sup7,100A2012000106-99-01,3-Butadiene197,100F2012007440-43-9Cadmiumandcadmiumcompounds158,100C2012000305-03-3Chlorambucil126,Sup7,100A2012000494-03-1Chlornaphazine14,Sup7,100A2012018540-29-9Chromium(VI)compounds149,100C2012Clonorchissinensis(infectionwith)161,100B2012Coal,indooremissionsfromhouseholdcombustionof195,100E2012Coalgasification192,100F2012008007-45-2Coal-tardistillation192,100F2012065996-93-2Coal-tarpitch135,Sup7,100F2012Cokeproduction192,100F2012000050-18-0006055-19-2Cyclophosphamide126,Sup7,100A2012059865-13-3079217-60-0Cyclosporine(seeciclosporin)000078-87-51,2-Dichloropropane141,Sup7,71,110inprep000056-53-1Diethylstilbestrol121,Sup7,100A2012Engineexhaust,diesel146,1052013Epstein-Barrvirus170,100B2012066733-21-9Erionite142,Sup7,100C2012Estrogen-onlymenopausaltherapy172,100A2012Estrogentherapy,postmenopausal(seeEstrogen-onlymenopausaltherapy)Estrogen-progestogenmenopausaltherapy(combined)172,91,100A2012Estrogen-progestogenoralcontraceptives(combined)(NB:Thereisalsoconvincingevidenceinhumansthattheseagentsconferaprotectiveeffectagainstcancerintheendometriumandovary)172,91,100A2012000064-17-5Ethanolinalcoholicbeverages196,100E20123AgentsClassifiedbytheIARCMonographs,Volumes1–112CASNoAgentGroupVolumeYear000075-21-8Ethyleneoxide(NB:OverallevaluationupgradedtoGroup1basedonmechanisticandotherrelevantdata)197,100F2012033419-42-0Etoposide(NB:OverallevaluationupgradedtoGroup1basedonmechanisticandotherrelevantdata)176,100A2012033419-42-0015663-27-1011056-06-7Etoposideincombinationwithcisplatinandbleomycin176,100A2012Fissionproducts,includingstrontium-901100D2012Fluoro-edenitefibrousamphibole1111Inprep000050-00-0Formaldehyde188,100F2012Haematitemining(underground)11,Sup7,100D2012Helicobacterpylori(infectionwith)161,100B2012HepatitisBvirus(chronicinfectionwith)159,100B2012HepatitisCvirus(chronicinfectionwith)159,100B2012Humanimmunodeficiencyvirustype1(infectionwith)167,100B2012Humanpapillomavirustypes16,18,31,33,35,39,45,51,52,56,58,59(NB:TheHPVtypesthathavebeenclassifiedascarcinogenictohumanscandifferbyanorderofmagnitudeinriskforcervicalcancer)164,90,100B2012HumanT-celllymphotropicvirustypeI167,100B2012Ionizingradiation(alltypes)1100D2012Ironandsteelfounding(occupationalexposureduring)134,Sup7,100F2012Isopropylalcoholmanufactureusingstrongacids1Sup7,100F2012Kaposisarcomaherpesvirus170,100B2012Leatherdust1100C2012Magentaproduction157,99,100F2012000148-82-3Melphalan19,Sup7,100A2012000298-81-7Methoxsalen(8-methoxypsoralen)plusultravioletAradiation124,Sup7,100A2012013909-09-6Methyl-CCNU1Sup7,100A2012000101-14-44,4'-Methylenebis(2-chloroaniline)(MOCA)(NB:OverallevaluationupgradedtoGroup1basedonmechanisticandotherrelevantdata)157,99,100F2012Mineraloils,untreatedormildlytreated133,Sup7,100F20124AgentsClassifiedbytheIARCMonographs,Volumes1–112CASNoAgentGroupVolumeYearMOPPandothercombinedchemotherapyincludingalkylatingagents1Sup7,100A2012000091-59-82-Naphthylamine14,Sup7,99,100F2012Neutronradiation(NB:OverallevaluationupgradedtoGroup1withsupportingevidencefromotherrelevantdata)175,100D2012Nickelcompounds149,100C2012016543-55-8064091-91-4N'-Nitrosonornicotine(NNN)and4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone(NNK)(NB:OverallevaluationupgradedtoGroup1basedonmechanisticandotherrelevantdata)189,100E2012Opisthorchisviverrini(infectionwith)161,100B2012Outdoorairpollution1109inprepOutdoorairpollution,parti